DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Seymour JF, Kipps TJ, Eichhorst B, Hillmen P, D'Rozario J, Assouline S. et al.
Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia.
N Engl J Med 2018;
378: 1107-20
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.